Background
Escherichia coli O157:H7 is an important foodborne pathogen associated with gastrointestinal illness, hemorrhagic colitis, and hemolytic uremic syndrome (HUS).
Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria, including E. coli O157:H7. LPS consists of three principal regions: lipid A, core oligosaccharide, and O-antigen. Because of its biological importance, LPS is widely investigated as a molecular target in bacterial endotoxin studies and biosensor development.
Fusion BioLabs offers a synthetic DNA aptamer exhibits high-affinity binding to purified E. coli O157 LPS. The confirmed apparent dissociation constant (Kd) is 2.0 ± 0.6 nM, determined using an enzyme-linked oligonucleotide assay (ELONA).
This aptamer also recognizes structurally diverse LPS preparations from other Gram-negative bacteria, making it potentially useful for broad-spectrum LPS recognition and research assay development.
Product Specification
Aptamer type: Single-stranded DNA (ssDNA)
Target: E. coli O157 Lipopolysaccharide (LPS)
Aptamer length: 30 nucleotides (30 nt)
Binding affinity (apparent Kd): 2.0 ± 0.6 nM
Affinity determination: ELONA using immobilized purified E. coli O157 LPS.
Specificity: Recognizes E. coli O157 LPS and cross-reacts with LPS from other Gram-negative bacteria.
Storage: Keep at −20°C. DNA aptamers are guaranteed stable for 12 months when properly stored.
Applications
- Lipopolysaccharide (LPS) binding studies
- Aptamer-based biosensor research and development
- Enzyme-linked oligonucleotide assay (ELONA) development
- Gram-negative bacterial endotoxin recognition studies
- Aptamer–LPS interaction and molecular recognition research
Research use: For research use only. Not intended for clinical diagnosis or therapeutic applications.
Looking for an aptamer against intact E. coli O157:H7 cells? See our APT-043 DNA Aptamer against E. coli O157:H7
